Loading...
You are viewing a DELETED record.
This record information is displayed for reference purpose only and should be not used.
This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Living Modified Organism
(LMO)
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
VAXXITEK® HVT+ IBD
EN
vHTV013-69
No
-
Person:Dra Luciana Fernanda Matias SoaresPresident of Internal Biosafety Commission, Animal HealthFazenda São Francisco s/nº - Caixa Postal: 242 - PAULINIA (SP)Paulínia, São Paulo
13140970, BrazilPhone: +55 19 3874-8601,Fax: +55 19 3874-8080,Email: luciana.soares@merial.com.br,Website: http://www.merial.com.br,Related OrganizationMerial Saúde Animal Ltda (Merial)Private sector (business and industry)Fazenda São Francisco s/nº - Caixa Postal: 242 - PAULINIA (SP)Paulínia, São Paulo
13140970, BrazilPhone: +55 19 3874-8601,Fax: +55 19 3874-8080,Email: luciana.soares@merial.com.br,Website: http://www.merial.com.br,
Vaxxitek HVT + IBD is a live vaccine based on the use of a recombinant turkey Herpesvirus (HVT) expressing the VP2 gene of the Infectious Bursal Disease (Gumboro disease) Virus (IBDV).
This vaccine contains a live strain of serotype 3 vectored virus that has been shown to aid in the prevention of Bursal disease and Marek's disease.
EN
This vaccine contains a live strain of serotype 3 vectored virus that has been shown to aid in the prevention of Bursal disease and Marek's disease.
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
-
BCH-ORGA-SCBD-105225-3 Organism Meleagrid alphaherpesvirus 1 (Turkey herpesvirus, Meleagrid herpesvirus 1)Viruses
Meleagrid herpesvirus 1 (HVT) strain: FC-126
EN
-
VECTORMUNE® HVT-IBD| Ceva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
vHVT013-69
EN
- Other (Homologous Recombination)
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
-
BCH-GENE-SCBD-105223-1 Viral Protein 2 gene | Infectious bursal disease virus (Gumboro virus)Protein coding sequence | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
Vaxxitek HVT + IBD vaccine is a live recombinant vaccine against Gumboro disease (or infectious bursal disease) and Marek’s disease in chickens. It is a frozen vaccine to be diluted with an aqueous diluent. The active ingredient is the production-cell associated vHVT013-69 virus vaccine strain, a recombinant turkey Herpesvirus (HVT) expressing the VP2 coding sequence of Infectious Bursal Disease Virus (IBDV). The parental strain of Vaxxitek HVT + IBD (named FC-126) belongs to the serotype 3 of Marek's disease and is widely used in classical vaccination against Marek's disease. HVT strains are apathogenic in all species, and do not replicate in mammalian cells. The inserted sequence corresponds to the sequence coding for the VP2 protein of Infectious Bursal Disease Virus (IBDV). It has been cloned from 52/70 Faragher strain. The VP2 protein is the only protein of IBDV that induces protection against Gumboro disease.
EN
EN
- Vaccine
EN
EN
- Vaxxitek HVT + IBD - MERIAL [ English ]
- VAXXITEK® HVT+ IBD - MERIAL [ English ]
Record type | Field | Record(s) | |||||
---|---|---|---|---|---|---|---|
|
|||||||
|